← Back to headlines
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss
Merck & Co. (MRK) is implementing measures to mitigate the impact of the upcoming loss of exclusivity for its drug KEYTRUDA.
15 Mar, 21:56 — 15 Mar, 21:56
Sources
Showing 1 of 1 sources
Related Stories
South Africa's Infrastructure Pipeline Expands to $16.5 Billion
12m ago
Danish Climate Minister Distances from Lolland Gas Pipeline After Factory Closure
24m ago
Wizz Air Offers to Take Over TAROM's Domestic Routes, Sparking Controversy
32m ago
Canada Retaliates Against US Tariffs with New Duties and Worker Aid Package
36m ago